Scott Fithian joined the Lord Companies in 1999. He brings strong sales,
marketing, strategic planning and project management expertise from his prior
management consulting.

At The Lord Companies, Scott has focused on brokerage and consulting for
small- to medium-size retail and mixed-use & developments. He represents a
wide range of owners and developers of new and rehabbed properties. In his
consulting capacity, Scott advises clients throughout the development process,
from developing the initial business plans and pro formas, all the way through to
final tenant build-out.

Scott has also completed several new real estate development projects
including an award-winning new construction townhouse project in the Lincoln
Square area, the conversion of a former storage building to a loft office building
in the West Loop and the conversion of a 110 unit mixed-use apartment
building in River North to condos and free-standing commercial spaces.

Scott’s primary focus is the Chicago urban market, with a particular expertise
in the “collar” neighborhoods surrounding the Loop. He has been a consistent
top performer, including being the top commercial producer in the Lake View
and Lincoln Park neighborhoods. Scott and his partner, Keith Lord, were
recently recognized as Chicago's top retail leasing owner's representation
brokers by CommercialForum (sponsored by the Chicago Association of
Realtors).

Prior to joining The Lord Companies, Scott ran his own real estate development
company where he did new multi-family construction. He was also the
Managing Director of SFA Advisory Group, a sales and marketing consulting
firm which he established in 1994. Overall, Scott had nearly 20 years of
experience in the medical / healthcare/life sciences industry. This included 10
years of senior sales, marketing, strategic planning and business development
experience with both large and small companies, including Abbott Laboratories,
Membrex, Serono-Baker Diagnostics, and Thermo Electron, plus nearly 10
years in management consulting and as a medical device industry analyst on
Wall Street with Lehman Brothers.